ELOA3CP

Across TCGA pan-cancer cohorts, ELOA3CP RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated ELOA3CP data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher ELOA3CP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ELOA3CP expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

CESC, READ, and BRCA are the cancer types where ELOA3CP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.124	0.798	<.001	108	view →
READ	OS	Tertile	All	0.166	0.830	<.001	90	view →
BRCA	OS	Tertile	All	0.560	0.925	<.001	66	view →
LUAD	OS	Tertile	III,IV	0.109	0.660	<.001	54	view →
LAML	DFS	Tertile	All	0.621	0.335	.019	36	view →
ESCA	OS	Tertile	III,IV	0.246	0.580	.020	18	view →
THCA	DFS	Tertile	All	0.178	0.842	.027	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

ELOA3CP–CESC (OS)

Open the CESC breakdown →